Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06888726
NA

Efficacy of Hi-tACS for Schizophrenia Negative Symptoms

Sponsor: Shanghai Mental Health Center

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to investigate whether Hi-tACS is effective and safe in treating negative symptoms of schizophrenia. Schizophrenic patients will receive treatment (Hi-tACS or shame stimulation) for 2 weeks. Negative symptoms, cognitive functioning, social functioning, and quality of life of intervention group and control group were assessed and compared between the two groups at baseline, 2 weeks, and 3 months post-intervention.

Official title: Efficacy of High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) in Treating Negative Symptoms of Schizophrenia

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-06-27

Completion Date

2026-11-30

Last Updated

2025-06-04

Healthy Volunteers

No

Interventions

DEVICE

High-intensity transcranial alternating current stimulation (Hi-tACS)

The equipment used is the transcranial microcurrent stimulator (Nexalin ADI), operated by trained therapists following standardized instructions. Three Nexalin conductive electrodes are placed on the patient's head. A 4.45×9.53 cm electrode is placed on the forehead, corresponding to the Fpz region of the 10/20 international standard electrode placement system. Two 3.18×3.81 cm electrodes are placed on the bilateral dorsolateral prefrontal cortex, corresponding to the F3 and F4 regions of the international standard electrode placement system. The stimulation frequency is 77.5 Hz, and the current intensity is 15 mA.

DEVICE

Sham High-intensity transcranial alternating current stimulation (Sham-Hi-tACS)

A sham device looks exactly the same as Nexalin ADI is used.

Locations (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China